ArticleThe Journal of pharmacy and pharmacology2020

A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine.

Bengt von Mentzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.